World's Best Scientists 2026 revealed!
Wiley A. Schell

Wiley A. Schell

D-Index & Metrics

Microbiology

D-Index
49
Citations
8568
World Ranking
4572
National Ranking
1767

Wiley A. Schell publication distribution in Microbiology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Microbiology in 2026. The highlighted bar marks where Wiley A. Schell sits on this spectrum.

55–64 publications: 8 scientists 65–74 publications: 29 scientists 75–84 publications: 55 scientists 85–94 publications: 112 scientists 95–104 publications: 137 scientists 105–114 publications: 190 scientists 115–124 publications: 235 scientists 125–134 publications: 234 scientists 135–144 publications: 288 scientists 145–154 publications: 264 scientists 155–164 publications: 264 scientists 165–174 publications: 253 scientists 175–184 publications: 276 scientists 185–194 publications: 190 scientists 195–204 publications: 233 scientists 205–214 publications: 207 scientists 215–224 publications: 198 scientists 225–234 publications: 155 scientists 235–244 publications: 161 scientists 245–254 publications: 160 scientists 255–264 publications: 146 scientists 265–274 publications: 139 scientists 275–284 publications: 148 scientists 285–294 publications: 115 scientists 295–304 publications: 96 scientists 305–314 publications: 88 scientists 315–324 publications: 106 scientists 325–334 publications: 65 scientists 335–344 publications: 76 scientists 345–354 publications: 64 scientists 355–364 publications: 62 scientists 365–374 publications: 65 scientists 375–384 publications: 61 scientists 385–394 publications: 34 scientists 395–404 publications: 44 scientists 405–414 publications: 36 scientists 415–424 publications: 35 scientists 425–434 publications: 29 scientists 435–444 publications: 33 scientists 445–454 publications: 34 scientists 455–464 publications: 25 scientists 465–474 publications: 26 scientists 475–484 publications: 20 scientists 485–494 publications: 19 scientists 495–504 publications: 16 scientists 505–514 publications: 17 scientists 515–524 publications: 23 scientists 525–534 publications: 14 scientists 535–544 publications: 14 scientists 545–554 publications: 18 scientists 555–564 publications: 12 scientists 565–574 publications: 7 scientists 575–584 publications: 9 scientists 585–594 publications: 9 scientists 595–604 publications: 9 scientists 605–614 publications: 7 scientists 615–624 publications: 9 scientists 625–634 publications: 7 scientists 635–644 publications: 4 scientists 645–654 publications: 5 scientists 655–664 publications: 6 scientists 665–674 publications: 7 scientists 675–678 publications: 3 scientists 679+ publications: 99 scientists
55 publications 679+

This scientist: 99 publications — 5th percentile

5% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 679 publications or more.

Wiley A. Schell D-index placement in Microbiology in 2026

The chart shows the D-index (discipline H-index) distribution of Microbiology scientists ranked by Research.com in 2026. The highlighted bar marks where Wiley A. Schell sits on this spectrum.

40 D-Index: 30 scientists 41 D-Index: 86 scientists 42 D-Index: 90 scientists 43 D-Index: 117 scientists 44 D-Index: 122 scientists 45 D-Index: 123 scientists 46 D-Index: 108 scientists 47 D-Index: 110 scientists 48 D-Index: 106 scientists 49 D-Index: 109 scientists 50 D-Index: 129 scientists 51 D-Index: 111 scientists 52 D-Index: 116 scientists 53 D-Index: 127 scientists 54 D-Index: 134 scientists 55 D-Index: 134 scientists 56 D-Index: 111 scientists 57 D-Index: 136 scientists 58 D-Index: 162 scientists 59 D-Index: 151 scientists 60 D-Index: 139 scientists 61 D-Index: 122 scientists 62 D-Index: 126 scientists 63 D-Index: 144 scientists 64 D-Index: 109 scientists 65 D-Index: 103 scientists 66 D-Index: 124 scientists 67 D-Index: 112 scientists 68 D-Index: 103 scientists 69 D-Index: 131 scientists 70 D-Index: 93 scientists 71 D-Index: 93 scientists 72 D-Index: 96 scientists 73 D-Index: 92 scientists 74 D-Index: 80 scientists 75 D-Index: 66 scientists 76 D-Index: 87 scientists 77 D-Index: 60 scientists 78 D-Index: 73 scientists 79 D-Index: 59 scientists 80 D-Index: 57 scientists 81 D-Index: 55 scientists 82 D-Index: 47 scientists 83 D-Index: 77 scientists 84 D-Index: 50 scientists 85 D-Index: 45 scientists 86 D-Index: 42 scientists 87 D-Index: 41 scientists 88 D-Index: 32 scientists 89 D-Index: 38 scientists 90 D-Index: 35 scientists 91 D-Index: 34 scientists 92 D-Index: 27 scientists 93 D-Index: 26 scientists 94 D-Index: 33 scientists 95 D-Index: 22 scientists 96 D-Index: 37 scientists 97 D-Index: 22 scientists 98 D-Index: 21 scientists 99 D-Index: 22 scientists 100 D-Index: 30 scientists 101 D-Index: 16 scientists 102 D-Index: 20 scientists 103 D-Index: 17 scientists 104 D-Index: 19 scientists 105 D-Index: 16 scientists 106 D-Index: 19 scientists 107 D-Index: 18 scientists 108 D-Index: 14 scientists 109 D-Index: 10 scientists 110 D-Index: 9 scientists 111 D-Index: 7 scientists 112 D-Index: 11 scientists 113 D-Index: 6 scientists 114 D-Index: 15 scientists 115 D-Index: 10 scientists 116 D-Index: 12 scientists 117 D-Index: 7 scientists 118 D-Index: 10 scientists 119 D-Index: 10 scientists 120 D-Index: 11 scientists 121 D-Index: 2 scientists 122 D-Index: 7 scientists 123 D-Index: 12 scientists 124 D-Index: 5 scientists 125 D-Index: 9 scientists 126 D-Index: 6 scientists 127+ D-Index: 95 scientists
40 D-Index 127+

This scientist: 49 D-Index — 18th percentile

18% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 127 D-Index or more.

Overview

Wiley A. Schell is affiliated with Duke University in the United States and specializes in the field of Medicine, with a focus on Epidemiology, Infectious Diseases, Organic Chemistry, Genetics, and Pulmonary and Respiratory Medicine. Their work encompasses a range of topics including fungal infections and studies, antifungal resistance and susceptibility, nail diseases and treatments, chronic lymphocytic leukemia research, synthesis and biological activity, respiratory and cough-related research, as well as cutaneous lymphoproliferative disorders research.

Recent publications by Wiley A. Schell demonstrate a concentration on fungal infections and antifungal therapies. Notable papers include:

  • Efficacy of APX2039 in a Rabbit Model of Cryptococcal Meningitis (2022) published in mBio
  • Susceptibility to Cryptococcus neoformans Infection with Bruton's Tyrosine Kinase Inhibition (2023) in Infection and Immunity
  • A ketogenic diet enhances fluconazole efficacy in murine models of systemic fungal infection (2024) in mBio
  • Black mold takes hold and story told (2020) in Medical Mycology Case Reports
  • Pharmacodynamics of ATI-2307 in a rabbit model of cryptococcal meningoencephalitis (2023) in Antimicrobial Agents and Chemotherapy

Wiley A. Schell has frequently published in several venues, primarily:

  • mBio
  • Open Forum Infectious Diseases
  • UNC Libraries
  • Infection and Immunity
  • Medical Mycology Case Reports

Collaboration is evident through recurring co-authorship with a number of researchers, including:

  • John R. Perfect (9 publications)
  • Charles Giamberardino (6 publications)
  • Jennifer L. Tenor (6 publications)
  • Dena L. Toffaletti (6 publications)
  • Julia R. Palmucci (4 publications)

The scientist's research is marked by contributions to fungal infection studies and antifungal susceptibility, reflected in consistent output over recent years. Their interdisciplinary approach draws upon expertise in epidemiology and organic chemistry to address challenges in infectious diseases, which is supported by a diverse publication record and multiple collaborative relationships.

Best Publications

  • Harnessing Hsp90 function as a powerful, broadly effective therapeutic strategy for fungal infectious disease

    Leah E. Cowen;Sheena D. Singh;Julia R. Köhler;Cathy Collins

  • Hsp90 governs echinocandin resistance in the pathogenic yeast Candida albicans via calcineurin.

    Sheena D. Singh;Nicole Robbins;Aimee K. Zaas;Wiley A. Schell

  • PKC Signaling Regulates Drug Resistance of the Fungal Pathogen Candida albicans via Circuitry Comprised of Mkc1, Calcineurin, and Hsp90

    Shantelle L. LaFayette;Cathy Collins;Aimee K. Zaas;Wiley A. Schell

  • Multiplexed Real-Time Polymerase Chain Reaction on a Digital Microfluidic Platform

    Zhishan Hua;Jeremy L. Rouse;Allen E. Eckhardt;Vijay Srinivasan

  • The New Fungal Opportunists Are Coming

    John R. Perfect;Wiley A. Schell

  • Structure-In Vitro Activity Relationships of Pentamidine Analogues and Dication-Substituted Bis-Benzimidazoles as New Antifungal Agents

    Maurizio Del Poeta;Wiley A. Schell;Christine C. Dykstra;Susan Jones

  • Preserving accuracy in GenBank

    Thomas D. Bruns;Meredith Blackwell;Ivan Edwards;Andy F.S. Taylor

  • Morphologic criteria for the preliminary identification of Fusarium, Paecilomyces, and Acremonium species by histopathology

    Katharine Liu;David N. Howell;David N. Howell;John R. Perfect;John R. Perfect;Wiley A. Schell;Wiley A. Schell

  • Calcineurin Is Essential for Candida albicans Survival in Serum and Virulence

    Jill R. Blankenship;Floyd L. Wormley;Molly K. Boyce;Wiley A. Schell

  • Cryptococcus neoformans-Cryptococcus gattii Species Complex: an International Study of Wild-Type Susceptibility Endpoint Distributions and Epidemiological Cutoff Values for Fluconazole, Itraconazole, Posaconazole, and Voriconazole

    A. Espinel-Ingroff;A.I. Aller;E. Canton;L.R. Castanon-Olivares

  • In vitro antifungal activity of pneumocandin L-743,872 against a variety of clinically important molds.

    M Del Poeta;W A Schell;J R Perfect

  • Correlation of in vitro fluconazole resistance of Candida isolates in relation to therapy and symptoms of individuals seropositive for human immunodeficiency virus type 1.

    M L Cameron;W A Schell;S Bruch;J A Bartlett

  • Diguanidino and "reversed" diamidino 2,5-diarylfurans as antimicrobial agents

    Chad E. Stephens;Farial Tanious;Susan Kim;W. David Wilson

  • Interlaboratory Comparison of Results of Susceptibility Testing with Caspofungin against Candida and Aspergillus Species

    Frank C. Odds;Mary Motyl;Roberto Andrade;Jacques Bille

  • Risk of Fungemia Due to Rhodotorula and Antifungal Susceptibility Testing of Rhodotorula Isolates

    Aimee K. Zaas;Molly Boyce;Wiley Schell;Barbara Alexander Lodge

  • Cryptococcus neoformans-Cryptococcus gattii Species Complex: an International Study of Wild-Type Susceptibility Endpoint Distributions and Epidemiological Cutoff Values for Amphotericin B and Flucytosine

    A. Espinel-Ingroff;A. Chowdhary;M. Cuenca-Estrella;A. Fothergill

  • Quantitation of Candida CFU in Initial Positive Blood Cultures

    Christopher D. Pfeiffer;Gregory P. Samsa;Wiley A. Schell;L. Barth Reller

  • In vitro and in vivo efficacies of the azole SCH56592 against Cryptococcus neoformans.

    J R Perfect;G M Cox;R K Dodge;W A Schell

  • In vitro interactions between antifungals and immunosuppressants against Aspergillus fumigatus.

    William J. Steinbach;Wiley A. Schell;Jill R. Blankenship;Chiatogu Onyewu

  • Gpr1, a putative G-protein-coupled receptor, regulates morphogenesis and hypha formation in the pathogenic fungus Candida albicans.

    Takuya Miwa;Yukinobu Takagi;Makiko Shinozaki;Cheol Won Yun

  • Preserving accuracy in GenBank

    M. I. Bidartondo;Thomas D. Bruns;Meredith Blackwell;Ivan Edwards

Frequent Co-Authors

John R. Perfect
John R. Perfect Duke University
Barbara D. Alexander
Barbara D. Alexander Duke University
William J. Steinbach
William J. Steinbach Duke University
Daniel K. Benjamin
Daniel K. Benjamin Duke University
Luis Ostrosky-Zeichner
Luis Ostrosky-Zeichner The University of Texas Health Science Center at Houston
Josep Guarro
Josep Guarro Rovira i Virgili University
John D. Turnidge
John D. Turnidge University of Adelaide
Thomas J. Walsh
Thomas J. Walsh Weill Cornell Medicine
M. Catherine Aime
M. Catherine Aime Purdue University West Lafayette
Joseph Heitman
Joseph Heitman Duke University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying microbiology opens doors to diverse career paths in healthcare and beyond. For those interested in combining clinical knowledge with patient care, becoming a functional medicine np salary is an attractive option offering rewarding work and competitive compensation.

Alternatively, careers in medical coding and health data management are rapidly growing fields. Earning certification as a certified professional coder (cpc) provides specialized skills essential for ensuring accuracy in medical billing and coding processes.

For a broader scope in healthcare administration, pursuing a bachelor of science in health information management salary can lead to dynamic roles managing patient data and healthcare systems.

Many students prefer flexible learning through online health information management programs cahiim accredited, which provide recognized credentials and practical expertise needed to excel in this evolving sector.

Best Scientists Citing Wiley A. Schell

Trending Scientists

Recently Published Articles